RAN 300 (Ranitidine Hydrochloride 300 mg)
Pill with imprint RAN 300 is Brown, Capsule-shape and has been identified as Ranitidine Hydrochloride 300 mg. It is supplied by Aurobindo Pharma Limited.
Ranitidine is used in the treatment of duodenal ulcer; erosive esophagitis; duodenal ulcer prophylaxis; gerd; cutaneous mastocytosis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RAN 300
Ranitidine Hydrochloride
- Imprint
- RAN 300
- Strength
- 300 mg
- Color
- Brown
- Size
- 19.00 mm
- Shape
- Capsule-shape
- Availability
- Rx and/or OTC
- Drug Class
- H2 antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aurobindo Pharma Limited
- Manufacturer
- Saraca Laboratories Limited
- National Drug Code (NDC)
- 59651-0145
- Inactive Ingredients
-
FD&C Blue No. 1,
FD&C Red No. 40,
FD&C Yellow No. 6,
magnesium stearate,
microcrystalline cellulose,
potassium hydroxide,
propylene glycol,
shellac,
sodium lauryl sulfate,
sodium starch glycolate type A potato,
ammonia,
titanium dioxide
Note: Inactive ingredients may vary.
Related Images for "RAN 300"
More about ranitidine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- En Español
- 153 Reviews
- Drug class: H2 antagonists
- FDA Alerts (18)
Consumer resources
- Patient Information
- Ranitidine Injection
- Ranitidine Suspension
- Ranitidine Syrup
- Ranitidine Tablets and Capsules
- Other brands
- Zantac
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.